Sitavia | Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

Adverse effects reported in at least 5% of patients receiving sitagliptin as monotherapy or add-on therapy with metformin and/or a thiazolidinedione or glimepiride and more commonly than with placebo include nasopharyngitis, upper respiratory tract infection, peripheral edema, and headache.
Adverse effects reported in at least 5% of patients receiving sitagliptin in combination with metformin and sulfonylurea (glimepiride) and more commonly than with placebo include hypoglycemia and headache.
Adverse effects reported in at least 5% of patients receiving sitagliptin in combination with insulin and more commonly than with placebo include hypoglycemia.

View ADR Reporting Link

Sitavia Adverse Reactions

sitagliptin

Manufacturer:

MacroPhar

Distributor:

MacroPhar Lab